pulmonary fibrosis alternative therapy

Alternative Therapy for Pulmonary Fibrosis

The Lung Institute offers patients with pulmonary fibrosis an alternative option for therapy in the form of cellular therapy. We are proud to be the only cellular therapy clinic in the world that focuses solely on treating chronic lung disease, and as such can offer an unparalleled level of understanding and experience in the treatment of pulmonary conditions utilizing cells.

The Lung Institute offers cellular therapy to treat pulmonary fibrosis:

  • Blood-Derived Therapy — During this procedure, blood is drawn from the patient and then harvested, processed and reintroduced intravenously into the patient’s body.

Because our alternative therapy uses autologous cells, or cells derived from the patient’s own body, this treatment option has virtually no risk of complications or rejection. The procedure is minimally invasive and performed on an outpatient basis over the course of two days. While there is currently no cure for pulmonary fibrosis, our cellular therapy has shown to potentially slow the progression of lung disease, minimize inflammation in the lungs and improve a person’s quality of life. In fact, more than 80 percent of people who have undergone treatment at the Lung Institute have reported an improvement in their quality of life following the procedure.

For more information about the innovative cellular therapy we offer as an alternative therapy to treat pulmonary fibrosis, call the Lung Institute team today at 888-745-6697. One of our caring team members will gladly help determine your candidacy for cellular therapy.

* Every patient is given a Patient Satisfaction Survey shortly after treatment. Responses to the 11-question survey are aggregated to determine patient satisfaction with the delivery of treatment.

^ Quality of Life Survey data measured the patient’s self-assessed quality of life and measurable quality of improvement at three months of COPD patients.

All claims made regarding the efficacy of Lung Institute's treatments as they pertain to pulmonary conditions are based solely on anecdotal support collected by Lung Institute. Individual conditions, treatment and outcomes may vary and are not necessarily indicative of future results. Testimonial participation is voluntary. Lung Institute does not pay for or script patient testimonials.

As required by Texas state law, the Lung Institute Dallas Clinic has received Institutional Review Board (IRB) approval from MaGil IRB, now Chesapeake IRB, which is fully accredited by the Association for the Accreditation of Human Research Protection Program (AAHRPP), for research protocols and procedures. The Lung Institute has implemented these IRB approved standards at all of its clinics nationwide. Approval indicates that we follow rigorous standards for ethics, quality, and protections for human research.

Each patient is different. Results may vary.